Jump to: Authorized Access | Attribution | Authorized Requests

Study Description

This study evaluated the multi-omic analysis of endothelial cells with a focus on von Willebrand factor regulation, and investigated aspects of endothelial regulation in the context of blood disorders. The data available at dbGaP consist of multi-omic analyses of these cells. 

Authorized Access
Publicly Available Data
  Link to other NCBI resources related to this study
Study Inclusion/Exclusion Criteria

Inclusion Criteria

1. Patients >= age of 1 with a specific blood disorder:

  • a bleeding disorder: Von Willebrand disease (VWD), Hemophilia, or other rare specific coagulation deficiencies
  • presence of history of a thrombus: venous thromboembolism, pulmonary embolism, arterial ischemic stroke, etc. 
  • sickle cell disease, including those with hemoglobin SS, hemoglobin SC, and other combinations resulting in clinical sickle cell disease
  • a specific vascular disease: pulmonary hypertension, atherosclerosis, peripheral arterial disease, etc.
  • blood dyscrasias or myeloproliferative disorders

2. Direct family members (age 1-99 years) of patients enrolled above. 

3. Healthy normal controls to establish a normal range of endothelial-specific outcomes.

Selected Publications
Diseases/Traits Related to Study (MeSH terms)
Authorized Data Access Requests
Study Attribution
  • Principal Investigator
    • Christopher Ng. Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
  • Funding Sources
    • 1P01HL144457-01. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
    • Grant. National Hemophilia Foundation, New York, NY, USA.
    • 5 H30 MC00008-20-00. Maternal & Child Health, Health Resources and Services Administration, Bethesda, MD, USA.